These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 3444237)

  • 1. [Inhibitors of leukotriene biosynthesis in the treatment of acute pancreatitis].
    Zemskov VS; Kolesnikov EB; Iuĭk AI; Voĭtenko GN; Maksiutina NP
    Klin Khir (1962); 1987; (11):31-3. PubMed ID: 3444237
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of flavonoids on arachidonic acid metabolism.
    Welton AF; Tobias LD; Fiedler-Nagy C; Anderson W; Hope W; Meyers K; Coffey JW
    Prog Clin Biol Res; 1986; 213():231-42. PubMed ID: 3086892
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of vitamin E and selenium on arachidonic acid oxidation by way of the 5-lipoxygenase pathway.
    Reddanna P; Whelan J; Burgess JR; Eskew ML; Hildenbrandt G; Zarkower A; Scholz RW; Reddy CC
    Ann N Y Acad Sci; 1989; 570():136-45. PubMed ID: 2516998
    [No Abstract]   [Full Text] [Related]  

  • 4. Pure enzymes in a test hierarchy for antibronchoconstrictory lipoxygenase inhibitors.
    Slapke J; Schewe T; Kühn H; Rapoport SM
    Biomed Biochim Acta; 1986; 45(10):1267-75. PubMed ID: 3105528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arachidonic acid-induced pleurisy (ARIP): an in vivo model for testing 5-lipoxygenase inhibition.
    Boctor AM; Burke C; Hovinga ME
    Methods Find Exp Clin Pharmacol; 1987 Dec; 9(12):793-7. PubMed ID: 2831442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic enhancement of mitogen responses of human lymphocytes by inhibitors of cyclo-oxygenase and lipoxygenase.
    Blomgren H; Hammarström S; Wasserman J
    Int Arch Allergy Appl Immunol; 1988; 86(1):62-8. PubMed ID: 3131257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Manipulations of arachidonic acid metabolism using a 5-lipoxygenase inhibitor in transfusion-induced immunosuppression.
    Heyd TJ; Perez RV; Trocki O; Alexander JW
    Transplant Proc; 1988 Dec; 20(6):1186-9. PubMed ID: 3144072
    [No Abstract]   [Full Text] [Related]  

  • 8. Screening of the influence of flavonoids on lipoxygenase and cyclooxygenase activity, as well as on nonenzymic lipid oxidation.
    Robak J; Shridi F; Wolbís M; Królikowska M
    Pol J Pharmacol Pharm; 1988; 40(5):451-8. PubMed ID: 3151014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5,6-methano leukotriene A4: a potent specific inhibitor for 5-lipoxygenase.
    Koshihara Y; Murota S; Nicolaou KC
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():163-7. PubMed ID: 6221521
    [No Abstract]   [Full Text] [Related]  

  • 10. Relative inhibitory potencies of flavonoids on 12-lipoxygenase of fish gill.
    Hsieh RJ; German JB; Kinsella JE
    Lipids; 1988 Apr; 23(4):322-6. PubMed ID: 3398718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Soy lipoxygenase as the object for the primary testing of potential inhibitors of leukotriene biosynthesis].
    Lototskaia LS; Naĭdenova IIu; Il'iasheva LM; Poda GI; Kornilov AI
    Farmakol Toksikol; 1989; 52(2):59-62. PubMed ID: 2501105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biosynthesis of leukotriene A4 from 5-hydroperoxyeicosatetraenoic acid: possible involvement of 8-lipoxygenase reaction.
    Shimizu T; Rådmark O; Samuelsson B
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():177-80. PubMed ID: 3004132
    [No Abstract]   [Full Text] [Related]  

  • 13. The development of new antileukotriene drugs: specific leukotriene D4 antagonists and 5-lipoxygenase inhibitors.
    Rokach J; Young RN
    Adv Exp Med Biol; 1989; 259():75-108. PubMed ID: 2560345
    [No Abstract]   [Full Text] [Related]  

  • 14. Syntheses of 5,6,7- and 5,7,8-trioxygenated 3',4'-dihydroxyflavones having alkoxy groups and their inhibitory activities against arachidonate 5-lipoxygenase.
    Horie T; Tsukayama M; Kourai H; Yokoyama C; Furukawa M; Yoshimoto T; Yamamoto S; Watanabe-Kohno S; Ohata K
    J Med Chem; 1986 Nov; 29(11):2256-62. PubMed ID: 3783588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific inhibition and oxidative regulation of 5-lipoxygenase.
    Egan RW; Tischler AN; Baptista EM; Ham EA; Soderman DD; Gale PH
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():151-7. PubMed ID: 6221519
    [No Abstract]   [Full Text] [Related]  

  • 16. Design, synthesis, and 5-lipoxygenase-inhibiting properties of 1-thio-substituted butadienes.
    Hanko R; Hammond MD; Fruchtmann R; Pfitzner J; Place GA
    J Med Chem; 1990 Apr; 33(4):1163-70. PubMed ID: 2319562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of sulfonated bioflavonoids on enzymatic oxidation of arachidonic acid and on non-enzymatic lipid oxidation.
    Robak J; Kopacz M
    Pol J Pharmacol Pharm; 1989; 41(5):469-73. PubMed ID: 2518221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arachidonate 5-lipoxygenase inhibitors show potent antiproliferative effects on human leukemia cell lines.
    Tsukada T; Nakashima K; Shirakawa S
    Biochem Biophys Res Commun; 1986 Nov; 140(3):832-6. PubMed ID: 3778487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiinflammatory consequences of 5-lipoxygenase inhibition.
    Ackerman NR; Arner EC; Galbraith W; Harris RR; Jaffee BD; Mackin WM
    Adv Prostaglandin Thromboxane Leukot Res; 1986; 16():47-62. PubMed ID: 2949564
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibitory effect of exogenous arachidonic acid on alveolar macrophage 5-lipoxygenase metabolism. Role of ATP depletion.
    Peters-Golden M; Shelly C
    J Immunol; 1988 Mar; 140(6):1958-66. PubMed ID: 3126237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.